two

  • Two Fold adds multi-groups capability to Qualoupe LIMS solution

    Two Fold Software has added a versatile multi-groups capability to its Qualoupe LIMS (Laboratory Information Management System) solution. The software enhancement offers complete data management flexibility for organizations and companies that not only have multiple sites but also include multiple laboratories within each site.

    two | 21 March 2012

  • BeiGene in-licenses two clinical-stage oncology compounds

    BeiGene will collaborate with Janssen in phase III clinical trials in melanoma and explore additional solid tumor indications in solid tumors prevalent in China and Asia.

    two | 15 October 2011

  • Novartis receives approval in Japan for two innovative therapies

    Approvals demonstrate ongoing Novartis commitment to bringing innovative treatments to patients in Japan.

    two | 27 September 2011

  • Networked drug development

    Strategies to reduce risk and increase pipeline activity.

    two | 01 July 2011

  • Clinical trial data support use of Levemir in children aged two to five years

    New clinical trial data just published in Pediatric Diabetes show that Levemir (insulin detemir), Novo Nordisk’s basal insulin analogue, is an equally efficacious treatment option for two to five year-old children with type 1 diabetes, compared wit…

    two | 23 March 2011

  • Two Fold: Web reporting module

    The web reporting module is integrated into the Qualoupe LIMS solution and runs on a concurrent licence basis. This allows contract laboratories or manufacturing companies to access and run LIMS reports on demand in a more cost-efficient way. Qu…

    two | 01 March 2011

  • Inno Biologics scores two firsts

    Inno Biologic has set two new landmarks: delivering the first batch of made-in-Malaysia clinical grade biopharma material and securing a letterof- intent to commercially manufacture biosimilars from India’s Avesthagen. Tapped in April 2010 to deve…

    two | 01 January 2011

  • Phase two clinical trial for universal influenza vaccine

    BiondVax Pharmaceuticals announces that it has received the approvals of the Ethics (“Helsinki”) Committees of the Institutional Review Boards (IRB) of both the Hadassah Clinical Research Center at Hadassah University Hospital in Jerusalem (Hada…

    two | 08 September 2010

  • J&J to Make 80 Submissions in Next Two Years

    Johnson & Johnson Medical Devices & Diagnostics (MD&D) segment has received more than a dozen regulatory approvals so far this year, and it plans to make approximately 80 significant submissions from across its seven franchises between 2010 and 2012…

    two | 14 June 2010

  • SP Scientific Expands German Distribution Network

    SP Scientific has announced an expansion in its network of specialist distributors that are serving the German market. The new structure will provide enhanced levels of sales, service and applications support for its Genevac evaporator and concentrat…

    two | 26 February 2010

Page 1 Next > Last >>